Most Popular
-
1
Dongduk Women’s University halts coeducation talks
-
2
Defense ministry denies special treatment for BTS’ V amid phone use allegations
-
3
Russia sent 'anti-air' missiles to Pyongyang, Yoon's aide says
-
4
OpenAI in talks with Samsung to power AI features, report says
-
5
Two jailed for forcing disabled teens into prostitution
-
6
Trump picks ex-N. Korea policy official as his principal deputy national security adviser
-
7
South Korean military plans to launch new division for future warfare
-
8
Gold bars and cash bundles; authorities confiscate millions from tax dodgers
-
9
Kia EV9 GT marks world debut at LA Motor Show
-
10
Teen smoking, drinking decline, while mental health, dietary habits worsen
[THE INVESTOR] South Korean shares opened higher on Oct. 4, amid rise in tech and auto shares.
The benchmark KOSPI scored 8.1 points, or 0.4 percent, to 2,051.73 in the first 15 minutes of trading.
Top market cap Samsung Electronics rose 1.19 percent ahead of its third-quarter earnings guidance release on Thursday, and leading automaker Hyundai Motor advanced 2.58 percent.
Bio stocks dropped sharply following heavy losses in the previous session.
Hanmi Pharmaceutical, the No. 1 player, tumbled 13.09 percent after it on Friday announced its license deal on a lung cancer treatment with German drug maker Boehringer Ingelheim ended. Its holding firm Hanmi Science also plummeted 14.21 percent.
The local currency was trading at 1,102.5 won against the US dollar, down 1.2 won from the previous session’s close.
(theinvestor@heraldcorp.com)
The benchmark KOSPI scored 8.1 points, or 0.4 percent, to 2,051.73 in the first 15 minutes of trading.
Top market cap Samsung Electronics rose 1.19 percent ahead of its third-quarter earnings guidance release on Thursday, and leading automaker Hyundai Motor advanced 2.58 percent.
Bio stocks dropped sharply following heavy losses in the previous session.
Hanmi Pharmaceutical, the No. 1 player, tumbled 13.09 percent after it on Friday announced its license deal on a lung cancer treatment with German drug maker Boehringer Ingelheim ended. Its holding firm Hanmi Science also plummeted 14.21 percent.
The local currency was trading at 1,102.5 won against the US dollar, down 1.2 won from the previous session’s close.
(theinvestor@heraldcorp.com)
